Related Experiment Video
Updated: Feb 15, 2026

Measuring Influenza Neutralizing Antibody Responses to AH3N2 Viruses in Human Sera by Microneutralization Assays Using MDCK-SIAT1 Cells
Published on: November 22, 2017
The impact of national vaccination policy changes on influenza incidence in the Netherlands
Scott A McDonald1, Liselotte van Asten1, Wim van der Hoek1
1Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Background:
We assessed the impact of two major modifications of the Dutch National Influenza Prevention Programme--the introduction in 1997 of free-of-charge vaccination to persons aged ≥65 years and to high-risk groups (previously only advised, and not free of charge), and the lowering of the eligible age to 60 years in 2008--on the estimated incidence of influenza infection leading to influenza-like illness (ILI).
Methods:
Additive negative-binomial segmented regression models were fitted to ILI data from GP sentinel surveillance in two-eight-season intervals (1993/4 to 2000/1, 2004/5 to 2011/12, comparing pre- and post-policy-change periods within each interval), with laboratory virological reporting of samples positive for influenza or other ILI-causing pathogens as covariates.
Results:
For the 2008 policy change, there was a significant step decrease in influenza contribution considering all ages (=-111 per 100 positives; 95% CI: -162, -65·0), <60 years and 60-64 years age groups (B = -92·1 per 100; 95% CI: -134, -55·5; B = -5·2; 95% CI: -10·3, -1·2, respectively). There was no evidence for a decrease associated with the 1997 policy change targeting the ≥65 years age group.
Conclusions:
In the Netherlands, a 56% reduction in influenza contribution was associated with the 2008 policy targeting 60-64 year-olds, but there was no effect of the earlier policy targeting ≥65-year-olds, for whom vaccination coverage was already rising before the policy change.
More Related Videos
10:39Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
Published on: June 25, 2015
13:12Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays
Published on: April 4, 2011
Related Concept Videos
Impact of Groups on Groups
Vaccinations
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
National Nursing Organizations I
National Nursing Organizations II
The AACN emphasizes a healthy work environment through six standards to achieve an optimal patient outcome. The standards are appropriate staffing, meaningful recognition, collaboration, authentic leadership, effective communication, and decision-making. In addition, AACN provides certification programs, webinars, journals, and...
Types of Reports II: Incident or Occurrence Report
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...